The gene therapy developer secured backing from Lundbeck and Alexandria Real Estate Equities in a series B round that will support the advancement of its clinical pipeline.

MassMutual Ventures and Advance Venture Partners returned to back the relationship management tool provider’s latest round, which brought its overall funding to $120m.

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

PayPal is to purchase its portfolio company Paidy, a consumer finance service provider. Paidy is part of the wider payment tech space, which has seen an increasing number of exits since last year.

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.

The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.

Allianz has recommitted to the venture capital firm having funded its $170m debut vehicle two years ago.